Design, synthesis, and evaluation of novel stilbene derivatives that degrade acidic nucleoplasmic DNA-binding protein 1 (And1) and synergize with PARP1 inhibitor in NSCLC cells-Reference-Cited by-同舟云学术

Design, synthesis, and evaluation of novel stilbene derivatives that degrade acidic nucleoplasmic DNA-binding protein 1 (And1) and synergize with PARP1 inhibitor in NSCLC cells

Published:2024-07-29 Issue:1 Volume:39 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Chen Leyuan¹,Ren Zhonghao²,Zhang Yunze³,Hou Wenbin¹,Li Yiliang¹

Affiliation:

1. Institute of Radiation Medicine, Peking Union Medical College & Chinese Academy of Medical Sciences, Tianjin, China

2. School of Life Sciences and Biopharmaceuticals, Shenyang Pharmaceutical University, Shenyang, China

3. School of Pharmacy, Tianjin Medical University, Tianjin, China

Funder

National Natural Science Foundation of China

the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

the Chinese Academy of Medical Sciences Innovation Fund for National Medical Health Science and Technology Platform

Natural Science Foundation of Tianjin City

the Fundamental Research Funds for the Central Universities

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2024.2383886

Reference32 articles.

1. The complementarity of DDR, nucleic acids and anti-tumour immunity;Kornepati AVR;Nature,2023

2. Targeting DNA damage response pathways in cancer

3. DNA damage repair deficiency and synthetic lethality for cancer treatment;Burdak-Rothkamm S;Trends Mol Med,2021

4. Small molecule tractable PARP inhibitors: Scaffold construction approaches, mechanistic insights and structure activity relationship;Thakur A;Bioorg Chem,2023

5. Discovery of quinazoline-2,4(1H,3H)-dione derivatives containing a piperizinone moiety as potent PARP-1/2 inhibitors─design, synthesis, in vivo antitumor activity, and X-ray crystal structure analysis;Zhou J;J Med Chem,2023